Jeito Capital
Jeito Capital is a leading global investment company focused on biopharmaceuticals. They finance and accelerate cutting-edge medical innovation with a patient benefit approach, supporting entrepreneurs through significant capital contributions and expert guidance.
Founded 2018 · Venture Capital
Paris (
France)
France)Investment Stages
Series A
Series B
Markets
Biopharmaceuticals
Oncology
Ophthalmology
Rare Skeletal Diseases
Severe Respiratory Diseases
Fibrosis
Immuno-oncology
Cardiovascular Disease
Immuno-Oncology Therapies
Auto-Immune Diseases
Neuromuscular Diseases
Cell Therapy
Gene Therapy
Portfolio Companies
Neogene Therapeutics, Sparing Vision, Pulmocide, Alentis Therapeutics, Quell Therapeutics, Advesya, NMD Pharma, EyeBio, Precirix, CDR-Life, HI-Bio, CatalYm, Noema Pharma, Corteria Pharmaceuticals
Related VC firms in France
360 Capital Partners
Deep Tech, Climate Tech, Digital-First
Acequia Capital
AI & Machine Learning, Commerce, New Industrials, Infrastructure, Logistics, Life Sciences, Gaming & Expression, Software & Knowledge Worker Tooling, Financial Technology
Aglaé Ventures
Marketplaces, SaaS, Platform, Consumer Apps, DNVB, Fintech, Financial Services